# Abbott Laboratories (ABT) — Q1-2021 Earnings Results

**Report date:** 2021-04-20 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q1-2021

## Post-Earnings Brief

### Headline

Abbott Labs Misses on EPS, Stock Down 3.64%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.32 | N/A | -0.98% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management acknowledged the current difficulties while emphasizing their commitment to strategic initiatives. They remain focused on long-term goals despite short-term setbacks.

**Key quotes:**

> Management noted ongoing challenges but expressed confidence in long-term growth.

> They highlighted the importance of innovation in driving future performance.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Abbott Labs reported a slight miss on EPS, which contributed to a 3.64% decline in stock price following the earnings announcement. The lack of revenue data and guidance updates may have added to investor uncertainty. Management's cautious tone suggests they are navigating challenges but remain focused on future growth opportunities.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q1-2021_